JPWO2022165067A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022165067A5 JPWO2022165067A5 JP2023545996A JP2023545996A JPWO2022165067A5 JP WO2022165067 A5 JPWO2022165067 A5 JP WO2022165067A5 JP 2023545996 A JP2023545996 A JP 2023545996A JP 2023545996 A JP2023545996 A JP 2023545996A JP WO2022165067 A5 JPWO2022165067 A5 JP WO2022165067A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- constant domain
- item
- igg
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163142774P | 2021-01-28 | 2021-01-28 | |
| US63/142,774 | 2021-01-28 | ||
| PCT/US2022/014146 WO2022165067A2 (en) | 2021-01-28 | 2022-01-27 | Mutations in canine antibody constant regions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024505072A JP2024505072A (ja) | 2024-02-02 |
| JPWO2022165067A5 true JPWO2022165067A5 (https=) | 2025-01-24 |
| JP2024505072A5 JP2024505072A5 (https=) | 2025-01-24 |
Family
ID=80786846
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023545996A Pending JP2024505072A (ja) | 2021-01-28 | 2022-01-27 | イヌ科動物抗体の定常領域における変異 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20240059777A1 (https=) |
| EP (2) | EP4284825A2 (https=) |
| JP (1) | JP2024505072A (https=) |
| KR (1) | KR20230136604A (https=) |
| CN (1) | CN116802205A (https=) |
| AU (1) | AU2022214843A1 (https=) |
| CA (1) | CA3207285A1 (https=) |
| CL (2) | CL2023002202A1 (https=) |
| CO (1) | CO2023009994A2 (https=) |
| EC (1) | ECSP23057156A (https=) |
| IL (1) | IL304522A (https=) |
| MX (1) | MX2023008785A (https=) |
| PE (1) | PE20231919A1 (https=) |
| TW (1) | TW202246318A (https=) |
| WO (1) | WO2022165067A2 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115996949A (zh) * | 2020-04-17 | 2023-04-21 | 硕腾服务有限责任公司 | 犬抗体变异体 |
| WO2022165067A2 (en) | 2021-01-28 | 2022-08-04 | Zoetis Services Llc | Mutations in canine antibody constant regions |
| CN119968390A (zh) * | 2022-09-02 | 2025-05-09 | 硕腾服务有限责任公司 | 猪抗体突变体 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5807715A (en) | 1984-08-27 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin |
| GB8422238D0 (en) | 1984-09-03 | 1984-10-10 | Neuberger M S | Chimeric proteins |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US6284471B1 (en) | 1991-03-18 | 2001-09-04 | New York University Medical Center | Anti-TNFa antibodies and assays employing anti-TNFa antibodies |
| US5698762A (en) | 1994-12-09 | 1997-12-16 | Dauerman; Leonard | Microwave-assisted pyrolysis of waste polyaromatic hydrocarbons |
| US20030031671A1 (en) | 2001-08-01 | 2003-02-13 | Sydney Welt | Methods of treating colon cancer utilizing tumor-specific antibodies |
| KR20070057839A (ko) | 2004-08-19 | 2007-06-07 | 제넨테크, 인크. | 변경된 이펙터 기능을 갖는 폴리펩티드 변이체 |
| US8367805B2 (en) | 2004-11-12 | 2013-02-05 | Xencor, Inc. | Fc variants with altered binding to FcRn |
| US8546543B2 (en) | 2004-11-12 | 2013-10-01 | Xencor, Inc. | Fc variants that extend antibody half-life |
| DK1817340T3 (da) | 2004-11-12 | 2012-08-13 | Xencor Inc | Fc-varianter med ændret binding til fcrn |
| US8790651B2 (en) | 2011-07-21 | 2014-07-29 | Zoetis Llc | Interleukin-31 monoclonal antibody |
| WO2018073185A1 (en) * | 2016-10-17 | 2018-04-26 | Vetoquinol Sa | Modified antibody constant region |
| CN113194984A (zh) * | 2018-10-18 | 2021-07-30 | 金德雷德生物科学股份有限公司 | 兽用的与新生儿Fc受体(FcRn)结合改变的Fc变体 |
| US11542333B2 (en) * | 2019-01-03 | 2023-01-03 | Invetx, Inc. | Compositions for increasing half-life of a therapeutic agent in canines and methods of use |
| WO2022165067A2 (en) | 2021-01-28 | 2022-08-04 | Zoetis Services Llc | Mutations in canine antibody constant regions |
-
2022
- 2022-01-27 WO PCT/US2022/014146 patent/WO2022165067A2/en not_active Ceased
- 2022-01-27 PE PE2023002227A patent/PE20231919A1/es unknown
- 2022-01-27 KR KR1020237025434A patent/KR20230136604A/ko active Pending
- 2022-01-27 JP JP2023545996A patent/JP2024505072A/ja active Pending
- 2022-01-27 EP EP22704666.1A patent/EP4284825A2/en active Pending
- 2022-01-27 EP EP24210430.5A patent/EP4512416A3/en active Pending
- 2022-01-27 MX MX2023008785A patent/MX2023008785A/es unknown
- 2022-01-27 AU AU2022214843A patent/AU2022214843A1/en active Pending
- 2022-01-27 CN CN202280010912.XA patent/CN116802205A/zh active Pending
- 2022-01-27 US US18/270,062 patent/US20240059777A1/en active Pending
- 2022-01-27 CA CA3207285A patent/CA3207285A1/en active Pending
- 2022-01-28 TW TW111104187A patent/TW202246318A/zh unknown
-
2023
- 2023-07-17 IL IL304522A patent/IL304522A/en unknown
- 2023-07-26 CL CL2023002202A patent/CL2023002202A1/es unknown
- 2023-07-27 CO CONC2023/0009994A patent/CO2023009994A2/es unknown
- 2023-07-27 EC ECSENADI202357156A patent/ECSP23057156A/es unknown
-
2024
- 2024-05-24 CL CL2024001562A patent/CL2024001562A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6703560B2 (ja) | 静電的ステアリング（ｅｌｅｃｔｒｏｓｔａｔｉｃ ｓｔｅｅｒｉｎｇ）効果を用いた抗体Ｆｃヘテロ二量体分子を作製するための方法 | |
| AU2016223095B2 (en) | Antibodies to tau and uses thereof | |
| JP2021530229A5 (https=) | ||
| MX2013011216A (es) | Metodo para tratar trastornos inmunitarios con anticuerpos de dominio sencillo contra tnf-alfa. | |
| CN114437212B (zh) | 抗人胸腺基质淋巴细胞生成素抗体及其制备方法和应用 | |
| RU2715606C2 (ru) | СЛИТАЯ С Fc α-ЦЕПЬ ВЫСОКОАФФИННОГО РЕЦЕПТОРА IgE | |
| JPWO2020018503A5 (https=) | ||
| RU2019123112A (ru) | Анти-il-5 антитела | |
| JP2015509714A5 (https=) | ||
| WO2009062238A1 (en) | Epitope for neutralizing antibodies | |
| JPWO2022165067A5 (https=) | ||
| WO2023118241A1 (en) | Anti-canine interleukine-31-receptor a (il-31ra) antibodies and the uses thereof | |
| JP2019518473A5 (https=) | ||
| JPWO2022226342A5 (https=) | ||
| CN115215937A (zh) | 抗人masp-2抗体及其制备方法和应用 | |
| KR102757647B1 (ko) | 고농도 조성물 및 피하 투여에 적합한 신규한 항-angptl3 항체 | |
| JPWO2021212081A5 (https=) | ||
| JP2022545925A (ja) | 抗ｔｆｐｉモノクローナル抗体 | |
| WO2016070769A1 (zh) | 同时阻断b7/cd28和il6/il6r/gp130信号通路的重组融合蛋白 | |
| AU2018423921B2 (en) | Anti-human interleukin 17A monoclonal antibody and application thereof | |
| KR102018608B1 (ko) | 목적하는 함량으로 불순물을 포함하는 TNFR-Fc 융합 단백질의 제조방법 | |
| JP6974500B2 (ja) | ＦｃＲｎに対するＩｇＧ様抗体の結合親和性を増加し、その血清半減期を延長させる方法 | |
| RU2025102187A (ru) | Мутанты бычьих антител | |
| RU2025105731A (ru) | Мутанты антител свиных | |
| JP3773556B2 (ja) | 抗アレルギー剤 |